WORCESTER BUSINESS JOURNAL – Marlborough technology company Persivia on Tuesday announced it launched a new module within its healthcare platform it says will use data from multiple sources to identify patients who may have a COVID-19 novel coronavirus infection.
The new surveillance module can be used with the company’s Soliton AI engine as part of its CareSpace platform. The module will be provided free to customers and uses data to help healthcare professionals more effectively target patients who need to be tested, according to the company.
Patients who are identified as having three or more relevant symptoms, as identified by U.S. Centers for Disease Control and Prevention guidelines, such as fever, shortness of breath, and cough, are flagged with a level one alert. The patient’s physician is prompted to educate the patient about COVID-19 and monitor their status. If Persivia also identifies a travel or exposure history the alert gets raised to a level two, where a CDC test is recommended.
Read the full article by Sam Bonacci here.